Adams Catherine Owen
Director · AGIOS PHARMACEUTICALS, INC.
- 2026
- Jun 23, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Adams Catherine Owen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Gheuens - $1.55M in AGIO purchases and sales in the last 12 months
- Brian Goff - $1.18M in AGIO purchases and sales in the last 12 months
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- James Kihara - $603K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adams Catherine Owen?
Adams Catherine Owen is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Adams Catherine Owen last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 4 filings going back to 2026.
Has Adams Catherine Owen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($250K) across all tracked filings.
